Skip to main content
OpenTrials

Clinical trial condition

Osteosarcoma

Explore clinical trials studying Osteosarcoma. Study availability and eligibility vary by location and protocol.

99 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Osteosarcoma trial results

Active, not recruiting

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

NCT05830084

Conditions
Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Queensland Children's Hospital Brisbane, Australia
  • Monash Children's Hospital Clayton, Australia
  • Royal Children's Hospital Parkville, Australia
  • Perth Children's Hospital Perth, Australia
View all 13 locations
View Trial Details
Active, not recruiting

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

NCT03709680

Conditions
Bone Diseases, Bone Neoplasms, Brain Diseases, +35 more
Locations
  • University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • MemorialCare Health System - Long Beach Medical Center Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 101 locations
View Trial Details
Completed

A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma

NCT05046314

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Completed

Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma

NCT01858168

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients

NCT04067115

Conditions
Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Boston Children's Hospital / Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details

Related conditions